Journals / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 3

Autophagy and liver cancer

Pages
270–282
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we summarized how our understanding of autophagy-cell death connection may have an impact on HCC therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Autophagy is a key biological phenomenon conserved from yeast to mammals.
📊
Key Findings & Data:Currently used treatment strategies in patients with HCC result in variable success rates.
💡
Conclusion & Impact:In this review, we summarized how our understanding of autophagy-cell death connection may have an impact on HCC therapy.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Autophagy is a key biological phenomenon conserved from yeast to mammals. Under basal conditions, activation of autophagy leads to the protein degradation as well as damaged organelles for maintaining cellular homeostasis. Deregulation of autophagy has been identified as a key mechanism contributing to the pathogenesis and progression of several liver diseases, including hepatocellular car-cinoma (HCC), one of the most common and mortal types of cancer. Currently used treatment strategies in patients with HCC result in variable success rates. Therefore, novel early diagnosis and treatment techniques should be developed. Manipulation of autophagy may improve responses of cancer cell to treatments and provide novel targeted therapy options for HCC. In this review, we summarized how our understanding of autophagy-cell death connection may have an impact on HCC therapy.

🔖

Cite This Article

AKKOÇ, Y., GÖZÜAÇIK, D. (2018). Autophagy and liver cancer. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 3, 270–282. https://ajindex.com/articles/410059

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tian Y, Sir D, Kuo CF, Ann DK, Ou JH. Autophagy required for hepatitis B virus replication in transgenic mice. J Virol 2011
  2. 13453-6. [CrossRef] 114. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010
  3. 42 Suppl 3: S206-14. [CrossRef] 113. Fan T, Zhang C, Zong M, Zhao Q, Yang X, Hao C, et al. Pepti-dylarginine deiminase IV promotes the development of chemoresis-tance through inducing autophagy in hepatocellular carcinoma. Cell Biosci 2014
  4. [CrossRef] 112. Kuo MT, Savaraj N, Feun LG. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading en-zymes. Oncotarget 2010
  5. Wu L, Li L, Meng S, Qi R, Mao Z, Lin M. Expression of arginino-succinate synthetase in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2013
  6. [CrossRef] 110. Altmeyer A, Josset E, Denis JM, Gueulette J, Slabbert J, Mutter D, et al. The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increas-ing autophagy. Int J Oncol 2012
  7. [CrossRef] 109. Altmeyer A, Ignat M, Denis JM, Messaddeq N, Gueulette J, Mut-ter D, et al. Cell death after high-LET irradiation in orthotopic human hepatocellular carcinoma in vivo. In Vivo 2011
  8. Altmeyer A, Jung AC, Ignat M, Benzina S, Denis JM, Gueulette J, et al. Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation. Anticancer Res 2010
  9. Xie HJ, Noh JH, Kim JK, Jung KH, Eun JW, Bae HJ, et al. HDAC1 inactivation induces mitotic defect and caspase-independent auto-phagic cell death in liver cancer. PLoS One 2012
  10. e34265. [CrossRef] 106. Liu YL, Yang PM, Shun CT, Wu MS, Weng JR, Chen CC. Autoph-agy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010
  11. [CrossRef] 105. Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Chang YG, et al. His-tone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent auto-phagic cell death in liver cancer. Hepatology 2012
  12. [CrossRef] 104. Zhong J, Dong X, Xiu P, Wang F, Liu J, Wei H, et al. Blocking au-tophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress. Cell Prolif 2015
  13. 704 [CrossRef] 103. Dong X, Li R, Xiu P, Dong X, Xu Z,